Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEJBB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,897
Award facts
- Contract value 100% obligated
- $17,896.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,896.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on February 2, 2026, was placed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The contract contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group has been registered in the System for Award Management since 2001 and serves as a critical pharmaceutical supplier for Department of Defense healthcare operations.
The delivery order calls for pharmaceutical products and medical consumables to support recurring medical supply needs of military healthcare facilities, with performance expected to conclude by February 3, 2026. As a regional prime vendor contractor under the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group supplies an extensive portfolio including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices to federal agencies. The company's established performance on numerous prior delivery orders demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEJBB?
SPE2DU26FEJBB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DU26FEJBB worth?
The government has obligated $17,897 on SPE2DU26FEJBB.
Is contract SPE2DU26FEJBB an order under another contract?
Yes. SPE2DU26FEJBB is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEJBB competed?
The extent of competition for SPE2DU26FEJBB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award